Glenn Sobotka's departure as Chief Accounting Officer of Astrana Health, Inc. was reported, effective August 7, 2026; the filing names no successor. As of November 6, 2026, Astrana Health, Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from May 12, 2026 to July 1, 2026, naming 2 departures (Form 8-K, July 1, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Astrana Health, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Astrana Health, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-05-12 to 2026-07-01. They name 2 people. Every row below is cited to the filing it comes from, and this page adds each new change as Astrana Health, Inc. files it.
Also on the record for Astrana Health, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 30, 2026 | Stake report, Schedule 13G/A, by Vanguard Portfolio Management | 4.74% of the class | 5%+ stakes | Source |
| July 31, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 5.34% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| January 30, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | 8.45% of the class | 5%+ stakes | Source |
| November 21, 2025 | Form D, private offering | $1.45M sold | Form D page | Source |
| July 29, 2025 | Stake report, Schedule 13G/A, by The Vanguard Group | 9.68% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Astrana Health, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Astrana Health, Inc. and the records around it.
Astrana Health, Inc. elsewhere on the record
- Form D filing Nov 2025
- Who owns it
Companies that share a holder
- Vanguard Portfolio Management also filed stake reports on 941 other companies: Newmark Group Inc (Nov 2026), A10 Networks Inc (Oct 2026), ADT Inc (Oct 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Watch Astrana Health, Inc.
Get an email when Astrana Health, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Astrana Health, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Astrana Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Astrana Health, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-07-01 | Out | Chief Accounting Officer | 2026-08-07 | 8-K, 2026-07-01 | |
| 2026-05-12 | Out | Chief Medical Officer | 2026-06-01 | 8-K, 2026-05-12 |
Who leads Astrana Health, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Accounting Officer: Glenn Sobotka, departure reported, effective 2026-08-07 (filed 2026-07-01). No successor is named in these filings.
- Chief Medical Officer: Dinesh Kumar, departure reported, effective 2026-06-01 (filed 2026-05-12). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Astrana Health, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Accounting Officer at Astrana Health, Inc., with the record behind each one.
Find candidates like Chief Accounting Officer at Astrana Health, Inc.Every change, in the filing's words
Departing: Glenn Sobotka, Chief Accounting Officer, effective 2026-08-07
On June 25, 2026, Glenn Sobotka, the Chief Accounting Officer and principal accounting officer of Astrana Health, Inc. (the "Company"), and the Company agreed that Mr. Sobotka will retire from his positions with the Company effective as of August 7, 2026.
- Mr. Sobotka's retirement is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies, or practices.
- John Vong, who has been appointed as Senior Vice President - Accounting effective July 1, 2026, will succeed Mr. Sobotka as the Company's principal accounting officer, effective as of August 7, 2026.
- Mr. Vong, 52, has previously served as the Company's Group Vice President, Accounting since March 2025.
- Prior to that, Mr. Vong served as the Company's Chief Accounting Officer and principal accounting officer from November 2022 to March 2025 and as its Vice President of Finance and Accounting from July 2022 to November 2022.
- Prior to joining the Company, Mr. Vong served as Vice President of Finance and Accounting at Prospect Medical Systems, Inc. from February 2016 to July 2022.
- Mr. Vong began his career as a certified public accountant with RSM.
- Mr. Vong received a Bachelor of Science degree in Business Administration from the University of California, Riverside and a Master of Business Administration degree from the University of California, Irvine.
- Effective as of July 1, 2026, Mr. Vong's annual base salary will increase to $320,000.
- Mr. Vong's target bonus opportunity as a percentage of his annual base salary for 2026 pursuant to his employee agreement remains unchanged.
Departing: Dinesh Kumar, Chief Medical Officer, effective 2026-06-01
On May 7, 2026, Dinesh Kumar, M.D., the Chief Medical Officer of Astrana Health, Inc. (the "Company"), notified the Company of his intention to resign, effective as of June 1, 2026.
- Dr. Kumar's resignation is not a result of any disagreement with the Company.
- The Company thanks Dr. Kumar for his contributions and wishes him the best in his future endeavors.
Tools for this story
Each opens in a new tab, filled in for Astrana Health, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.